This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Knowledge Hub

Immunization can prevent severe long-term impacts of infections, including seizures and hearing loss

In The Gambia, 58% of children who survived pneumococcal meningitis had long lasting negative health outcomes. Half had major disabilities such as mental retardation, hearing loss, motor abnormalities, and seizures.

Full Citation:
Goetghebuer, T., West, T.E., Wermenbol, V., et al. 2000. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Tropical Medicine and International Health. 5(3).

Title of Article: Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

Author(s): Goetghebuer, T., West, T.E., Wermenbol, V., et al

Publication Year: 2000

Publication Name: Tropical Medicine and International Health

Publication Volume: 5(3)

Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/10747284/

DOI (Digital Object Identifier): 10.1046/j.1365-3156.2000.00535.x

Topics: Health

Disease Vaccines: Meningitis | Pneumococcal disease/PCV/PPSV

Countries: Gambia

WHO Regions: Africa